NCT05648019
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR, +28 more
- Locations
-
- Singapore General Hospital Singapore
- KK Women's and Children's Hospital Singapore
Clinical trial condition
Burkitt Lymphoma
Explore clinical trials studying Burkitt Lymphoma. Study availability and eligibility vary by location and protocol.
695 public trials
115 recruiting studies
Burkitt Lymphoma trial results
NCT05210907
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT05518383
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Diffuse Large B-cell Lymphoma, +19 more
- Locations
-
- Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology and Immunology Moscow, RF, Russia
NCT04746209
- Conditions
- B-Cell ALL, Childhood, B-cell Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States
NCT03869619
- Conditions
- Burkitt Lymphoma, Burkitt Lymphoma (BL)), DNA Virus Infections, +26 more
- Locations
-
- Unité d'Hématologie Clinique, CH D'ARRAS Arras, France
- Service d'Hématologie, CHU Jean Minjoz Besançon, France
- Service d'Onco-radiolothérapie, Polyclinique Bordeaux Nord Aquitaine Bordeaux, France
- Institut Bergonié Bordeaux, France
Not Yet Recruiting
Study Of KITE-753 in R/R B-Cell ALL
NCT07674823
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- UT MD Anderson Houston, Texas, United States
Not Yet Recruiting
Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma
NCT07724457
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
- Locations
-
Not specified
Not Yet Recruiting
Pre-emptive Anakinra for Cytokine Event Reduction
NCT06703216
- Conditions
- B-Acute Lymphoblastic Leukemia, Burkitt Lymphoma, CAR-T Cell Therapy, +24 more
- Locations
-
- Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
Not Yet Recruiting
Epcoritamab in Combination With Dose Adjusted EPOCH-R for High-risk Burkitt Lymphoma (BL), The BEDROCK Study
NCT07662928
- Conditions
- Adult Burkitt Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +15 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Not Yet Recruiting
A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic Leukemia
NCT07313852
- Conditions
- B-ALL, B-Cell Acute Lymphoblastic Leukemia, Adult, B-cell Acute Lymphoblastic Leukemia, +17 more
- Locations
-
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States